Bio Solution Co., Ltd. · KRX:086820

Bio Solution Co., Ltd. financial statements

Bio Solution Co., Ltd.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in KRW

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue15.2B12.9B12.5B10.1B11.8B7.74B8.88B10.5B5.01B3.20B
Cost of revenue5.61B4.73B4.40B4.17B4.19B3.44B2.98B3.51B2.47B1.90B
Gross profit9.59B8.16B8.06B5.93B7.61B4.30B5.90B7.01B2.54B1.30B
Research and development6.31B5.75B4.39B3.84B3.66B3.23B1.99B1.77B1.45B
Selling, general and administrative3.74B6.49B7.37B6.36B4.83B3.74B3.58B3.77B2.42B2.84B
Operating income-4.34B-10.1B-5.14B-5.29B-1.57B-3.33B-1.87B1.08B-1.81B-3.13B
Depreciation and amortization2.18B1.87B2.55B2.00B1.62B1.80B1.54B487.5M489.5M427.5M
EBITDA-2.16B-8.21B-2.59B-3.29B49.4M-1.53B-331.2M1.57B-1.33B-2.70B
Interest expense2.81B3.13B3.26B3.07B1.09B40.5M0000
Income before tax273.4M-11.9B-1.36B-8.09B-1.68B-1.80B-697.5M1.35B-1.81B-3.09B
Net income273.4M-11.9B-1.36B-8.09B-1.68B-1.80B-697.5M1.35B-1.81B-3.09B
Earnings per share, basic10.59-495.55-56.35-335.97-210.90-225.77-88.12174.40-295.66-505.54

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents11.9B12.9B5.49B13.4B29.0B3.39B1.51B2.77B493.1K575.0K
Short-term investments211.7M1.43B32.2B59.4B54.1B32.8B39.0B42.1B800.0M1.91B
Receivables4.84B4.64B4.18B4.01B2.32B2.73B3.57B2.85B1.29B2.15B
Inventory1.25B1.49B1.45B1.47B1.20B1.33B529.8M693.0M616.0M549.9M
Current assets19.4B21.0B44.2B79.2B87.1B40.7B44.8B48.5B4.30B5.34B
Property, plant and equipment6.45B6.91B8.45B3.95B5.23B4.11B1.82B1.94B2.29B
Total assets68.5B67.5B92.3B91.7B94.4B49.8B51.8B52.9B7.38B8.82B
Accounts payable255.7M458.7M278.1M173.1M149.1M195.4M98.9M226.3M257.5M253.3M
Current liabilities34.2B33.4B47.1B45.9B48.9B2.02B2.81B1.82B1.53B1.53B
Total debt653.0M150.5M
Total liabilities36.5B36.2B50.2B48.0B49.4B3.13B3.71B3.80B2.96B2.70B
Shareholders' equity32.0B31.3B42.1B43.8B45.0B46.7B48.1B49.1B4.42B6.12B
Shares outstanding25.8M24.1M24.1M24.1M7.99M7.97M7.92M7.73M6.11M6.11M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations-1.31B-2.29B2.16B-3.81B83.3M-1.69B-2.61B1.03B-78.5M-2.07B
Capital spending-731.5M-1.23B-1.16B-4.08B-663.1M-1.39B-2.18B-707.5M-187.8M-1.14B
Free cash flow-2.04B-3.51B1.00B-7.90B-579.9M-4.19B-4.79B318.7M-266.3M-3.21B
Cash from investing24.3B-9.69B-12.2B-17.2B3.76B795.9M-43.1B874.1M-27.2M
Cash from financing-14.7B-441.6M415.7M42.6B-172.0M541.7M43.4B43.4B1.40B
Share buybacks0350.0M169.4M508.5M1.21B43.4B1.40B
Change in cash-1.04B7.44B-7.96B-15.5B25.6B1.88B-1.26B1.30B795.3M-698.1M